Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy
Technology appraisal guidance
Reference number: TA758
Published:
Please note that the company have requested additional time in order to facilitate a suitably comprehensive and robust evidence submission. NICE have agreed to this and the new deadline for submissions is expected to be early-January 2020.